Comparative Effectiveness of Anti-TNF Therapy and Vedolizumab in Crohn's Disease Patients

被引:0
作者
Chen, Nai-Yu [1 ]
Chiu, Yung-Ting [1 ]
Chuang, Chiao-Hsiung [2 ]
Chang, Yu-Ching [3 ]
Cheng, Ching-Lan [1 ]
机构
[1] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Dept Internal Med, Med Coll & Hosp, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan, Taiwan
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
816
引用
收藏
页码:356 / 356
页数:1
相关论文
共 50 条
[31]   Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth? [J].
Liu, Kecheng ;
Cai, Fuqing ;
Huang, Jiean .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (07) :1253-1254
[32]   Cost-effectiveness of natalizumab in patients with Crohn's disease who have failed Anti-TNFα therapy [J].
Sands, Bruce ;
Wolf, Douglas ;
Panjabi, Sumeet ;
Niecko, Timothy ;
Hass, Steven ;
Lacey, Loretto .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 :S401-S402
[33]   Does The Sequence Matter ? Comparative effectiveness of a second line biologic in patients with Ulcerative Colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab [J].
Miller, C. ;
Kwok, H. ;
Parisi, I. ;
Harrow, P. ;
McCartney, S. ;
Vega, R. ;
Rahman, F. ;
Seward, E. ;
Mehta, S. ;
Lim, S. ;
Sharma, E. ;
Samaan, M. ;
Bancil, A. ;
Kok, K. ;
Shalabi, A. ;
Johnston, E. ;
Katarey, D. ;
Taherzadeh, N. ;
Murray, C. ;
Sharip, M. ;
Carter, M. ;
Radhakrishnan, S. ;
Peake, S. ;
Khakoo, I. ;
Wahed, M. ;
Povlsen, S. ;
Patel, M. ;
Dubois, P. ;
Finkel, J. ;
Onnie, C. ;
Bloom, S. .
JOURNAL OF CROHNS & COLITIS, 2021, 15 :S443-S444
[34]   Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti-TNF-refractory Crohn's disease [J].
Townsend, Tristan ;
Razanskaite, Violeta ;
Dodd, Susanna ;
Storey, Daniel ;
Michail, Stephanie ;
Morgan, James ;
Davies, Michael ;
Penman, Douglas ;
Watters, Christopher ;
Swaminathan, Mira ;
Sabine, Joseph ;
Chapman, Adam ;
Smith, Philip J. ;
Flanagan, Paul K. ;
Reilly, Ian ;
Bodger, Keith ;
Subramanian, Sreedhar .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) :1341-1352
[35]   Effectiveness of nutritional and anti-TNF therapy in North American children with active Crohn's disease [J].
Lee, D. Y. ;
Baldassano, R. N. ;
Compher, C. W. ;
Griffiths, A. M. ;
Otley, A. R. ;
Albenberg, L. G. ;
Wu, G. D. ;
Bushman, F. D. ;
Lewis, J. D. .
JOURNAL OF CROHNS & COLITIS, 2014, 8 :S420-S420
[36]   Effectiveness of Vedolizumab Therapy for Crohn's Disease [J].
Kessing, Richard .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (12) :1443-1443
[37]   Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn's disease [J].
Dussias, N. ;
Rizzello, F. ;
Calabrese, C. ;
Passino, A. Sanna ;
Melotti, L. ;
Scaioli, E. ;
Belluzzi, A. ;
Gionchetti, P. .
JOURNAL OF CROHNS & COLITIS, 2021, 15 :S528-S528
[38]   COMPARISON OF SHORT AND LONG-TERM EFFICACY BETWEEN USTEKINUMAB AND VEDOLIZUMAB IN PATIENTS WITH CROHN'S DISEASE REFRACTORY TO ANTI-TNF THERAPY [J].
Manlay, Luc ;
Boschetti, Gilles ;
Pereira, Bruno ;
Buisson, Anthony ;
Nancey, Stephane .
GASTROENTEROLOGY, 2021, 160 (06) :S6-S6
[39]   Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study [J].
Cassandra Rayer ;
Maria Nachury ;
Arnaud Bourreille ;
Xavier Roblin ;
Laurent Peyrin-Biroulet ;
Stephanie Viennot ;
Mathurin Flamant ;
David Laharie ;
Bénédicte Caron ;
Marie Dewitte ;
Laurent Siproudhis ;
Mathurin Fumery ;
Guillaume Bouguen .
BMC Gastroenterology, 22
[40]   Single Center Experience With Long-term Ustekinumab in Patients With Refractory Crohn's Disease (Prior Anti-TNF and Vedolizumab Therapy) [J].
Bennett, Audrey L. ;
Evers, Lauren ;
Duley, Caroline V. ;
Annis, Kim ;
Beaulieu, Dawn B. ;
Adams, Dawn W. ;
Schwartz, David A. ;
Horst, Sara N. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 :S397-S398